Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response

Tumor Biology

Volumn 37, Issue 6, 2016, Pages 8349-8358

  Gong, Wei Jing ^a,b   Yin, Ji Ye ^a,b   Li, Xiang Ping ^a   Fang, Chao ^a,b   Xiao, Di ^a,b   Zhang, Wei ^a,b   Zhou, Hong Hao ^a,b   Li, Xi ^a,b   Liu, Zhao Qian ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study   (China)

Author keywords

Long non coding RNA; Lung cancer; Platinum based chemotherapy response; Polymorphism; Susceptibility

Indexed keywords

DOCETAXEL; ETOPOSIDE; GEMCITABINE; IRINOTECAN; LONG UNTRANSLATED RNA; NAVELBINE; PACLITAXEL; PEMETREXED; PLATINUM COMPLEX; RNA H19; ANRIL LONG NON-CODING RNA, HUMAN; ANTINEOPLASTIC AGENT; H19 LONG NON-CODING RNA; HOTAIR LONG UNTRANSLATED RNA, HUMAN; LONG NON-CODING RNA CCAT2, HUMAN; LONG NONCODING RNA HOTTIP, HUMAN; MALAT1 LONG NON-CODING RNA, HUMAN;

ADULT; ALLELE; ANRIL GENE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CCAT2 GENE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; H19 GENE; HOTAIR GENE; HOTTIP GENE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALAT1 GENE; MALE; MEG3 GENE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SEX DIFFERENCE; SMALL CELL LUNG CANCER; SMOKING; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; LUNG NEOPLASMS; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANTINEOPLASTIC AGENTS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, LONG NONCODING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84952905741     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4497-5     Document Type: Article

References (35)

1. Parkin D, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993;54:594–606.
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
3. Chen W, Zheng R, Zeng H, Zhang S, He J. Annual report on status of cancer in china, 2011. Chin J Cancer Res. 2015;27:2.
4. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.
5. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629–41.
6. Koziol MJ, Rinn JL. RNA traffic control of chromatin complexes. Curr Opin Genet Dev. 2010;20:142–8.
7. Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S, et al. Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature. 2002;420:563–73.
8. Li XP, Yin JY, Wang Y, He H, Li X, Gong WJ, et al. The atp7b genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients. Tumor Biol. 2014;35:8259–65.
9. Yin JY, Huang Q, Yang Y, Zhang JT, Zhong MZ, Zhou HH, et al. Characterization and analyses of multidrug resistance-associated protein 1 (mrp1/abcc1) polymorphisms in Chinese population. Pharmacogenet Genomics. 2009;19:206.
10. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci. 2009;106:9362–7.
11. Liu Y, Pan S, Liu L, Zhai X, Liu J, Wen J, et al. A genetic variant in long non-coding rna hulc contributes to risk of hbv-related hepatocellular carcinoma in a Chinese population. PLoS One. 2012;7:e35145.
12. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205–16.
13. Deng H, Chen L, Fan T, Zhang B, Xu Y, Geng Q. Long non-coding RNA hottip promotes tumor growth and inhibits cell apoptosis in lung cancer. Cell Mol Biol (Noisy-le-Grand France). 2014;61:34–40.
14. JiP D, Wang W. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22:8031.
15. Schmidt LH, Spieker T, Koschmieder S, Humberg J, Jungen D, Bulk E, et al. The long noncoding malat-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol. 2011;6:1984–92.
16. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, et al. Long non-coding RNA malat-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012;29:1810–6.
17. Gabory A, Jammes H, Dandolo L. The h19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays. 2010;32:473–80.
18. Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T. Frequent loss of imprinting of the h19 gene is often associated with its overexpression in human lung cancers. Oncogene. 1995;10:1193–8.
19. Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, et al. The c-myc oncogene directly induces the h19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2006;66:5330–7.
20. Tsang W, Kwok T. Riboregulator h19 induction of mdr1-associated drug resistance in human hepatocellular carcinoma cells. Oncogene. 2007;26:4877–81.
21. Verhaegh GW, Verkleij L, Vermeulen SH, den Heijer M, Witjes JA, Kiemeney LA. Polymorphisms in the h19 gene and the risk of bladder cancer. Eur Urol. 2008;54:1118–26.
22. Riaz M, Berns EM, Sieuwerts AM, Ruigrok-Ritstier K, de Weerd V, Groenewoud A, et al. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Breast Cancer Res Treat. 2012;133:843–51.
23. Yang C, Tang R, Ma X, Wang Y, Luo D, Xu Z, Zhu Y, Yang L. Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population. Oncotarget 2015.
24. Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, et al. Ccat2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013;23:1446–61.
25. Qiu M, Xu Y, Yang X, Wang J, Hu J, Xu L, et al. Ccat2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumor Biol. 2014;35:5375–80.
26. Nakagawa T, Endo H, Yokoyama M, Abe J, Tamai K, Tanaka N, et al. Large noncoding RNA hotair enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer. Biochem Biophys Res Commun. 2013;436:319–24.
27. Liu Z, Sun M, Lu K, Liu J, Zhang M, Wu W, et al. The long noncoding RNA hotair contributes to cisplatin resistance of human lung adenocarcinoma cells via downregulation of p21 (waf1/cip1) expression. PLoS One. 2013;8:e77293.
28. Xue Y, Gu D, Ma G, Zhu L, Hua Q, Chu H, et al. Genetic variants in lncrna hotair are associated with risk of colorectal cancer. Mutagenesis. 2015;30:303–10.
29. Guo W, Dong Z, Bai Y, Guo Y, Shen S, Kuang G, et al. Associations between polymorphisms of hotair and risk of gastric cardia adenocarcinoma in a population of North China. Tumor Biol. 2015;36:2845–54.
30. Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia R, et al. Long noncoding RNA ANRIL promotes non–small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther. 2015;14:268–77.
31. Yap KL, Li S, Muñoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone h3 lysine 27 by polycomb cbx7 in transcriptional silencing of ink4a. Mol Cell. 2010;38:662–74.
32. Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg AP, et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature. 2008;451:202–6.
33. Yuan XW, Zhu XF, Huang XF, Sheng PY, He AS, Yang ZB, et al. P14arf sensitizes human osteosarcoma cells to cisplatin-induced apoptosis in a p53-independent manner. Cancer Biol Ther. 2007;6:1074–80.
34. Deng X, Kim M, Vandier D, Jung YJ, Rikiyama T, Sgagias MK, et al. Recombinant adenovirus-mediated p14 arf overexpression sensitizes human breast cancer cells to cisplatin. Biochem Biophys Res Commun. 2002;296:792–8.
35. Al-Mohanna MA, Manogaran PS, Al-Mukhalafi Z, Al-Hussein KA, Aboussekhra A. The tumor suppressor p16ink4a gene is a regulator of apoptosis induced by ultraviolet light and cisplatin. Oncogene. 2004;23:201–12.